137,55 €
0,05 % heute
L&S, 18. Juli, 08:54 Uhr
ISIN
US14149Y1082
Symbol
CAH
Berichte

Cardinal Health Aktie News

Negativ
24/7 Wall Street
2 Tage alt
Key Points in This Article: Holding onto stocks that have significantly appreciated, rather than cashing out for short-term gains, preserves long-term portfolio growth and avoids capital gains taxes.
Neutral
PRNewsWire
3 Tage alt
DUBLIN, Ohio , July 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2025 on August 12, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
Neutral
PRNewsWire
7 Tage alt
DUBLIN, Ohio , July 11, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the launch of the Cardinal Health™ One Voice Initiative for pharmacy advocacy, which provides direct financial assistance to state pharmacy associations for the purpose of supporting independent pharmacists' advocacy efforts.   This investment furthers Cardinal Health's longstanding advocacy around the futu...
Positiv
24/7 Wall Street
16 Tage alt
Dividend stocks are a favorite among investors for good reason.
Positiv
Seeking Alpha
19 Tage alt
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%.
Positiv
The Motley Fool
22 Tage alt
The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
Positiv
Reuters
etwa ein Monat alt
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
Neutral
PRNewsWire
etwa ein Monat alt
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4 Raising lon...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen